• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    LifeStance Names Vaughn Paunovich as Chief Technology Officer

    5/14/25 9:00:00 AM ET
    $LFST
    Medical/Nursing Services
    Health Care
    Get the next $LFST alert in real time by email

    SCOTTSDALE, Ariz., May 14, 2025 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that Vaughn Paunovich will join the company as Chief Technology Officer, effective Monday, June 9, 2025. Paunovich will lead LifeStance's end-to-end technology strategy, ensuring that the organization continues to deliver a best-in-class technology experience for its patients and clinicians.

    LifeStance Health Logo (PRNewsfoto/LifeStance Health)

    "Vaughn brings a demonstrated track record of leading high-performing technology teams and delivering digital experiences that improve the patient and provider experience, which aligns perfectly with our mission at LifeStance," said Dave Bourdon, CEO, LifeStance. "As we continue to increase access to our services and deliver care at scale across the country, we believe Vaughn is the right leader to successfully execute on our long-term technology roadmap while ensuring we provide a high-quality experience for our patients and clinicians."

    Paunovich is an experienced health care technology executive with over 25 years of experience leading digital transformation initiatives. Most recently, he served as EVP, Enterprise Platforms at Amwell, where he was responsible for leading the product and technology teams as they drove digital transformation for patients, clinicians, payor and provider organizations. Prior to Amwell, Paunovich spent ten years at UnitedHealth Group in a variety of leadership roles including Chief Information Officer of Optum Health, where he led technology and innovation spanning the provider and patient care ecosystem.

    "I'm thrilled to join LifeStance and build on the organization's strong momentum to transform how mental health care is delivered in our country," said Paunovich. "I look forward to partnering with LifeStance's exceptional team to advance our digital strategy, improve access to care and build scalable, patient-centered technologies that support our mission to help people lead healthier, more fulfilling lives."

    Paunovich replaces Pablo Pantaleoni, who is stepping down from his role. Since joining the company in 2020, Pantaleoni played a pivotal role in LifeStance's digital transformation, with a focus on building an exceptional digital experience for both patients and clinicians. Pantaleoni will work closely with Paunovich to ensure a seamless transition.

    ABOUT LIFESTANCE HEALTH

    Founded in 2017, LifeStance (NASDAQ:LFST) is reimagining mental health. We are one of the nation's largest providers of virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Our mission is to help people lead healthier, more fulfilling lives by improving access to trusted, affordable and personalized mental healthcare. LifeStance and its supported practices employ approximately 7,500 psychiatrists, advanced practice nurses, psychologists and therapists and operate across 33 states and more than 550 centers. To learn more, please visit www.LifeStance.com.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/lifestance-names-vaughn-paunovich-as-chief-technology-officer-302454684.html

    SOURCE LifeStance Health

    Get the next $LFST alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LFST

    DatePrice TargetRatingAnalyst
    5/27/2025$8.50Neutral → Buy
    UBS
    4/8/2025$9.00Overweight
    KeyBanc Capital Markets
    4/3/2025$8.00Buy
    Canaccord Genuity
    12/16/2024$10.00Neutral → Buy
    Goldman
    1/3/2024$7.00Underweight
    Barclays
    5/15/2023$8.00 → $9.00Outperform → Market Perform
    TD Cowen
    1/6/2023$8.00Equal-Weight → Overweight
    Morgan Stanley
    11/7/2022$7.25Buy
    Jefferies
    More analyst ratings

    $LFST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • LifeStance Health Group upgraded by UBS with a new price target

      UBS upgraded LifeStance Health Group from Neutral to Buy and set a new price target of $8.50

      5/27/25 9:06:20 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • KeyBanc Capital Markets initiated coverage on LifeStance Health Group with a new price target

      KeyBanc Capital Markets initiated coverage of LifeStance Health Group with a rating of Overweight and set a new price target of $9.00

      4/8/25 9:29:32 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • Canaccord Genuity initiated coverage on LifeStance Health Group with a new price target

      Canaccord Genuity initiated coverage of LifeStance Health Group with a rating of Buy and set a new price target of $8.00

      4/3/25 8:18:32 AM ET
      $LFST
      Medical/Nursing Services
      Health Care

    $LFST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Medical Officer Ramtekkar Ujjwal sold $49,213 worth of shares (9,519 units at $5.17), decreasing direct ownership by 8% to 103,916 units (SEC Form 4)

      4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

      6/18/25 4:00:04 PM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • Chief Technology Officer Paunovich Vukasin was granted 178,571 shares (SEC Form 4)

      4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

      6/13/25 7:37:34 PM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • Director Shuey Eric was granted 35,714 shares, increasing direct ownership by 61% to 93,982 units (SEC Form 4)

      4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

      6/13/25 7:36:25 PM ET
      $LFST
      Medical/Nursing Services
      Health Care

    $LFST
    SEC Filings

    See more
    • SEC Form 8-K filed by LifeStance Health Group Inc.

      8-K - LifeStance Health Group, Inc. (0001845257) (Filer)

      6/6/25 7:30:16 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • LifeStance Health Group Inc. filed SEC Form 8-K: Regulation FD Disclosure

      8-K - LifeStance Health Group, Inc. (0001845257) (Filer)

      5/14/25 9:34:10 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by LifeStance Health Group Inc.

      10-Q - LifeStance Health Group, Inc. (0001845257) (Filer)

      5/7/25 4:42:46 PM ET
      $LFST
      Medical/Nursing Services
      Health Care